Medical School

Hematology, Oncology and Transplantation

Department of Medicine

Hematology, Oncology and Transplantation

MEDDOM2 Weisdorf Photo first page
Division Chief

Daniel Weisdorf, MD

Chief
Division of Hematology, Oncology
and Transplantation

Director
Adult Blood and Marrow
Transplantation Program

DOMHOT PWB and Moos 2013 JPG
Announcements

Emil Lou, MD, PhD received a Mezin-Koats Colon Cancer Research Award from the Masonic Cancer Center. The Mezin-Koats Colon Cancer Research Award, designed to support research that advances the treatment of colon cancer, will support Dr. Lou and his research team in their efforts to determine whether tunneling nanotubes act as a physical conduit for intercellular transfer of oncogenic KRAS and miRNAs in colon cancer. Long and narrow, tunneling nanotubes are membrane structures that provide a physical channel for the transfer of cellular contents from one cell to another. Dr. Lou’s studies will examine the role of tunneling nanotubes in mediating direct intercellular transfer of oncogenic KRAS and microRNAs and their effects on recipient tumor cells. The ultimate goal of Dr. Lou’s project is to establish a novel biologic mechanism of cancer cell communication that can be targeted with inhibitors of tunneling nanotubes. Please join us in congratulating Dr. Lou and his research team on their receipt of a Mezin-Koats Colon Cancer Research Award. Posted November 2014.

Kalpna Gupta’s work on pain in sickle cell disease was highlighted in a news article published in a November 2014 issue of Nature. The article, titled “Neurobiology: Life beyond the pain,” is part of a special supplemental issue of Nature covering sickle cell disease. Posted November 2014.

Dan Kaufman, MD, PhD was a featured speaker at the 2014 International Stem Cell Forum (ISCF),held in Tianjin, China on November 1-3, 2014  (see photo). Organized by the Chinese Academy of Medical Sciences and several other Chinese research institutes, the ISCF aims to foster international collaborations and multi-disciplinary stem cell research. This year’s ISCF featured internationally renowned stem cell researchers discussing hematopoietic stem cell development and transplantation, along with other topics related to hematopoietic stem cell biology. Dr. Kaufman was the co-chair of the session on stem cell reprogramming and gave a presentation entitled “Use of human pluripotent stem cell-derived blood cells for anti-cancer therapy.” Posted November 2014.

  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on November 11, 2013